These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10715061)

  • 1. Hepatic parenchymal enhancement during triple-phase helical CT: can it be used to predict which patients with breast cancer will develop hepatic metastases?
    Sheafor DH; Killius JS; Paulson EK; DeLong DM; Foti AM; Nelson RC
    Radiology; 2000 Mar; 214(3):875-80. PubMed ID: 10715061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT.
    Platt JF; Francis IR; Ellis JH; Reige KA
    Radiology; 1997 Oct; 205(1):49-53. PubMed ID: 9314961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of parenchymal enhancement on dual-phase dynamic helical CT of the liver: how long does the hepatic arterial phase predominate?
    Frederick MG; McElaney BL; Singer A; Park KS; Paulson EK; McGee SG; Nelson RC
    AJR Am J Roentgenol; 1996 Jun; 166(6):1305-10. PubMed ID: 8633437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic haemodynamics: interrelationships between contrast enhancement and perfusion on CT and Doppler perfusion indices.
    Fuentes MA; Keith CJ; Griffiths M; Durbridge G; Miles KA
    Br J Radiol; 2002 Jan; 75(889):17-23. PubMed ID: 11806953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases.
    Leslie DF; Johnson CD; MacCarty RL; Ward EM; Ilstrup DM; Harmsen WS
    AJR Am J Roentgenol; 1995 Dec; 165(6):1403-6. PubMed ID: 7484574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma.
    Sheafor DH; Frederick MG; Paulson EK; Keogan MT; DeLong DM; Nelson RC
    AJR Am J Roentgenol; 1999 Apr; 172(4):961-8. PubMed ID: 10587129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings.
    Soyer P; Poccard M; Boudiaf M; Abitbol M; Hamzi L; Panis Y; Valleur P; Rymer R
    Radiology; 2004 May; 231(2):413-20. PubMed ID: 15044747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small hypoattenuating hepatic lesions at contrast-enhanced CT: prognostic importance in patients with breast cancer.
    Krakora GA; Coakley FV; Williams G; Yeh BM; Breiman RS; Qayyum A
    Radiology; 2004 Dec; 233(3):667-73. PubMed ID: 15516602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography.
    Kim SH; Lee WJ; Lim HK; Lim JH
    J Comput Assist Tomogr; 2007; 31(2):198-203. PubMed ID: 17414753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in global hepatic enhancement assessed by dynamic CT in normal subjects and patients with hepatic metastases.
    Platt JF; Francis IR; Ellis JH; Reige KA
    J Comput Assist Tomogr; 1997; 21(3):348-54. PubMed ID: 9135639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing.
    Mitsuzaki K; Yamashita Y; Ogata I; Nishiharu T; Urata J; Takahashi M
    AJR Am J Roentgenol; 1996 Sep; 167(3):753-7. PubMed ID: 8751695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of injection rates of contrast material on arterial phase hepatic CT.
    Kim T; Murakami T; Takahashi S; Tsuda K; Tomoda K; Narumi Y; Oi H; Nakamura H
    AJR Am J Roentgenol; 1998 Aug; 171(2):429-32. PubMed ID: 9694469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer with synchronous and metachronous hepatic metastasis predicted by enhancement pattern on multiphasic contrast-enhanced CT.
    Tsurumaru D; Nishimuta Y; Muraki T; Asayama Y; Nishie A; Oki E; Honda H
    Eur J Radiol; 2018 Nov; 108():165-171. PubMed ID: 30396650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cirrhotic liver enhancement on dual-phase helical CT: comparison with noncirrhotic livers in 146 patients.
    Vignaux O; Legmann P; Coste J; Hoeffel C; Bonnin A
    AJR Am J Roentgenol; 1999 Nov; 173(5):1193-7. PubMed ID: 10541087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoid metastases to the liver: role of triple-phase helical CT.
    Paulson EK; McDermott VG; Keogan MT; DeLong DM; Frederick MG; Nelson RC
    Radiology; 1998 Jan; 206(1):143-50. PubMed ID: 9423664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helical CT of the liver: value of an early hepatic arterial phase.
    Bonaldi VM; Bret PM; Reinhold C; Atri M
    Radiology; 1995 Nov; 197(2):357-63. PubMed ID: 7480677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic CT enhancement: comparison of ionic and nonionic contrast agents in the same patients.
    Chambers TP; Baron RL; Lush RM; Dodd GD; Miller WJ
    Radiology; 1994 Mar; 190(3):721-5. PubMed ID: 8115618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic enhancement in colorectal cancer: texture analysis correlates with hepatic hemodynamics and patient survival.
    Ganeshan B; Miles KA; Young RC; Chatwin CR
    Acad Radiol; 2007 Dec; 14(12):1520-30. PubMed ID: 18035281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of customized scan timing determined by tracking liver enhancement in oncology patients.
    Zamboni GA; Gourtsoyianni S; Sourlas E; Raptopoulos VD
    J Comput Assist Tomogr; 2009; 33(2):253-8. PubMed ID: 19346855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT arterial portography of the abdomen: effect of injecting papaverine into the mesenteric artery on hepatic contrast enhancement.
    Soyer P; Lacheheb D; Levesque M
    AJR Am J Roentgenol; 1993 Jun; 160(6):1213-5. PubMed ID: 8498218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.